The role of Treg cells in colorectal cancer and the immunotherapy targeting Treg cells
Colorectal cancer (CRC) is among the most prevalent and lethal cancers globally, accounting for approximately 10% of all cancer cases and deaths. Regulatory T (Treg) cells, which accumulate in CRC tissue, suppress anti-tumor immune responses and facilitate tumor progression. This review discusses Tr...
Saved in:
| Main Authors: | Hanqing Yu, Ruiliang Yang, Meixiang Li, Dan Li, Yuanqing Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1574327/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances and future perspectives of neoadjuvant immunotherapy in colorectal cancer
by: ZHANG Yuyang, LIU Qian
Published: (2025-07-01) -
The role of ferroptosis in colorectal cancer and its potential synergy with immunotherapy
by: Wenhua Xia, et al.
Published: (2025-01-01) -
Research progress of immune checkpoint inhibitors in neoadjuvant immunotherapy for dMMR/MSI-H locally advanced colorectal cancer
by: Zhu Xi, et al.
Published: (2024-02-01) -
Insights into immune-related adverse events in colorectal cancer patients receiving neoadjuvant immunotherapy: findings from a multicenter registry study
by: Chentong Wang, et al.
Published: (2025-06-01) -
Gut Microbiota Reshapes the Tumor Microenvironment and Affects the Efficacy of Colorectal Cancer Immunotherapy
by: Fayuan Wang, et al.
Published: (2025-06-01)